Iqgen-X Pharma Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.

2016 Navi Mumbai, Maharashtra, India Active

Last Updated: December 29, 2025

About Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited, a active private limited company, was established on 13 October 2016 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U74999MH2016PTC286716. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.13 Cr.

It upholds a compliant status. Employing 34 professional, Its leadership includes Yatendra Kumar (Director), Karan Jasjit Singh (Additional Director), Yogita Mandar Kodgule (Director). Past directors included Prabhakaran Balakrishnan Nair, Mousumi Satyanarayana Vemula, Urmila Devi Vemula. It holds ₹2.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at A-165, Ttc Industrial Area, Khairane., Navi Mumbai, Maharashtra, 400705.

Company Details

CIN/LLPIN
U74999MH2016PTC286716
Registration Number
286716
Incorporation Date
13 October 2016
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.13 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 29-12-2025
Paid Up Capital ₹ 1.13 Cr as on 29-12-2025
Company Age 9 Year, 4 Months
Last Filing with ROC 31 Mar 2023
Open Charges ₹ 2.28 Cr as on 29-12-2025
Revenue Growth **** -13.64% (FY 2023)
Profit Growth **** 86.35% (FY 2023)
Ebitda **** 373.39% (FY 2023)
Net Worth 5.17% (FY 2023)
Total Assets -3.00% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Iqgen-X Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Iqgen-X Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Yatendra Kumar	Director	01 Apr 2017	Current
Karan Jasjit Singh	Additional Director	16 Oct 2020	Current
Yogita Mandar Kodgule	Director	01 Apr 2017	Current
Mandar Madhukar Kodgule	Director	01 Apr 2017	Current
Madhu Hariharan	Director	01 Apr 2017	Current
Parizad Adil Elchidana	Additional Director	30 Sep 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Director	16 Jul 2020	Past
Pramod Abcsdd	Director	01 Apr 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iqgen-X Pharma.

Iqgen-X Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.64% decrease. The company also saw a substantial improvement in profitability, with a 86.35% increase in profit. The company's net worth moved up by a moderate rise of 5.17%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-13.64%

*******

Revenue from Operations

*******

-13.79%

*******

Total Assets

*******

-3.00%

*******

Profit or Loss

*******

86.35%

*******

Net Worth

*******

5.17%

*******

EBITDA

*******

373.39%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iqgen-X Pharma?

In 2023, Iqgen-X Pharma had a promoter holding of 40.80% and a public holding of 59.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹22,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Canara Bank : 2.28 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Jul 2020	Canara Bank	₹2.80 M	Open
25 Sep 2017	Canara Bank	₹2.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Iqgen-X Pharma?

Iqgen-X Pharma has a workforce of 34 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Iqgen-X Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iqgen-X Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iqgen-X Pharma

Recent Activity within the Organization

Annual General Meeting

The activity Iqgen-X Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
30 Sep 2023
Balance Sheet

The activity Iqgen-X Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
31 Mar 2023
Director Appointment

The activity Parizad Adil Elchidana was appointed as a Additional Director was appointed as a Additional Director on 30 Sep 2021 & has been associated with this company since 4 years 4 months . was completed.
30 Sep 2021
Director Appointment

Progress on Karan Jasjit Singh was appointed as a Additional Director was appointed as a Additional Director on 16 Oct 2020 & has been associated with this company since 5 years 3 months . was documented.
16 Oct 2020
Charges

The activity A charge with Canara Bank of Rs. 2.00 Cr registered on 25 Sep 2017 with Charge ID 100135679 was modified on 29 Aug 2020. was completed.
29 Aug 2020
Charges

A charge with Canara Bank amounted to Rs. 0.28 Cr with Charge ID 100355277 was registered on 28 Jul 2020. was recorded as a recent event.
28 Jul 2020

Explore recent activity and updates - View Recent Activity